Patent details

Basic Information

Publication number:

EP2707384

PCT Application Number:

US2012037648

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127821700

PCT Publication Number:

WO2012155107

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF

French Title of Invention:

ANALOGUES DE LA COMPSTATINE CIBLÉS, À LONGUE DURÉE D'ACTION, RÉACTIFS AUX CELLULES, ET LEURS UTILISATIONS

German Title of Invention:

ZELLREAKTIVE, LANGWIRKENDE ODER GEZIELTE COMPSTATIN-ANALOGA UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

11/05/2012

Grant date:

06/04/2022

EP Publication Date:

19/03/2014

PCT Publication Date:

15/11/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/04/2022

EP B1 Publication Date:

06/04/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/05/2022

Expiration date:

11/05/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/03/2022

 

 

Name:

Apellis Pharmaceuticals, Inc.

Address:

100 5th Avenue, Waltham, MA 02451, United States (US)

Inventor

1

Name:

DESCHATELETS, Pascal

Address:

United States (US)

2

Name:

FRANCOIS, Cedric

Address:

United States (US)

Priority

Priority Number:

201161484836 P

Priority Date:

11/05/2011

Priority Country:

United States (US)

Classification

IPC classification:

C07K 7/00; A61K 38/04; C12N 5/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

202214

Publication date:

06/04/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages